NYSE - Nasdaq Real Time Price USD

Edwards Lifesciences Corporation (EW)

75.15

-0.74

(-0.98%)

At close: June 13 at 4:00:02 PM EDT

75.02

-0.13

(-0.17%)

After hours: June 13 at 6:52:28 PM EDT

Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 14 days ago

ARAY

EW
-0.98%
How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals

Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.

Investor's Business Daily 17 days ago

BSX

MDT

EW
-0.98%
Edwards’ study demonstrates value in early aortic stenosis intervention

The study found that early intervention led to an 80% reduction in heart failure hospitalisations one year after treatment.

Medical Device Network 21 days ago

EW
-0.98%

GLDAF
Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock

EW's new late-breaking clinical data shows early intervention in AS may slash significant costs and improve patient outcomes.

Zacks 22 days ago

EW
-0.98%
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick

Investing.com -- Citi analysts revised their MedTech coverage following a volatile first quarter, with several rating changes and adjustments to target prices.

Investing.com 23 days ago

EW
-0.98%

COO
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

PARIS, May 22, 2025--Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of research on this disease.

Business Wire 23 days ago

EW
-0.98%
Jim Cramer Notes Edwards Lifesciences (EW) is in a “Good Zone”

We recently published a list of Jim Cramer’s Recent Thoughts on These 15 Stocks. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other stocks that Jim Cramer discussed recently. On Monday, Mad Money host Jim Cramer addressed the market’s reaction to the recent U.S. debt […]

Insider Monkey 24 days ago

EW
-0.98%
Insider Action In Asian Undervalued Small Caps

In recent weeks, Asian markets have experienced a positive shift in sentiment, buoyed by the temporary de-escalation of trade tensions between the U.S. and China, which has helped lift indices such as China's CSI 300 and Hong Kong's Hang Seng Index. In this environment, identifying small-cap stocks that are potentially undervalued requires careful consideration of factors like market positioning and growth potential amidst evolving economic conditions.

Simply Wall St. 25 days ago

EW
-0.98%

SPZ.AX

9638.HK
Should Edwards Lifesciences Stock Remain in Your Portfolio Now?

EW stock is on investors' radars due to the promising structural heart opportunities and impressive TMTT portfolio.

Zacks 29 days ago

EW
-0.98%

CAH
Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs […]

Insider Monkey last month

EW
-0.98%
Edwards Lifesciences First Quarter 2025 Earnings: EPS Beats Expectations

Edwards Lifesciences ( NYSE:EW ) First Quarter 2025 Results Key Financial Results Revenue: US$1.41b (up 6.2% from 1Q...

Simply Wall St. last month

EW
-0.98%
Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Bristol-Myers Squibb Co. (BMY) and Canadian Pacific Kansas City Ltd. (CP), as well a micro-cap stock Nova LifeStyle, Inc. (NVFY).

Zacks last month

CP

CELG-RT

VZ
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

IRVINE, Calif., May 06, 2025--Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.

Business Wire last month

EW
-0.98%
Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients

Edwards Lifesciences (NYSE:EW) recently celebrated the FDA approval of its SAPIEN 3 TAVR therapy for asymptomatic aortic stenosis patients, a significant development in cardiac care. This milestone, coupled with robust Q1 earnings and updated financial guidance, likely bolstered investors' confidence, contributing to a 5% share price increase over the past month. The company’s advancements align with broader market trends, marked by a 2% rise, driven by strong earnings and positive economic...

Simply Wall St. last month

EW
-0.98%
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients

Edwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients.

Medical Device Network last month

EW
-0.98%

GLDAF
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

IRVINE, Calif., May 01, 2025--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform, for severe aortic stenosis (AS) patients without symptoms, marking the first FDA approval for TAVR in asymptomatic patients.

Business Wire last month

EW
-0.98%
Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite?

We recently published a list of How Did Jim Cramer’s 12 Bold Predictions Play Out?. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other stocks that Jim Cramer recently discussed. During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in […]

Insider Monkey last month

EW
-0.98%

BSX
Dow Jones Aerospace Giant Boeing Nears Buy Point; Spotify Earnings Imminent

Dow Jones aerospace giant Boeing is approaching a new buy point, while Spotify earnings loom ahead of the market open Tuesday.

Investor's Business Daily last month

EW
-0.98%

SPOT

MELI
Edwards Shoots Higher As It Shrugs Off Tariffs Worries — Until 2026

Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.

Investor's Business Daily last month

EW
-0.98%
Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings

Edwards Lifesciences (NYSE:EW) recently announced its updated guidance, projecting second-quarter 2025 sales between $1.45 billion and $1.53 billion, alongside first-quarter results showing a rise in sales and net income compared to the previous year. This aligns with a broader market trend where the S&P 500 and Nasdaq Composite surged, driven by positive earnings reports and easing concerns over tariffs. The company's 2.2% price move over the last quarter reflects the general optimism but...

Simply Wall St. last month

EW
-0.98%

Performance Overview

Return	EW	S&P 500 (^GSPC)
YTD	+1.51%	+1.62%
1-Year	-14.28%	+10.00%
3-Year	-15.13%	+59.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Edwards Lifesciences Corporation (EW)

Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?

How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals

Edwards’ study demonstrates value in early aortic stenosis intervention

Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock

Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

Jim Cramer Notes Edwards Lifesciences (EW) is in a “Good Zone”

Insider Action In Asian Undervalued Small Caps

Should Edwards Lifesciences Stock Remain in Your Portfolio Now?

Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now

Edwards Lifesciences First Quarter 2025 Earnings: EPS Beats Expectations

Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients

FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite?

Dow Jones Aerospace Giant Boeing Nears Buy Point; Spotify Earnings Imminent

Edwards Shoots Higher As It Shrugs Off Tariffs Worries — Until 2026

Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings

Performance Overview